Welcome to the Deater Foundation website for information on HSAN1!
2022 HSAN1 SYMPOSIUM RECORDING IS NOW LIVE.
Thank you for your participation in the HSAN1 Symposium that will be held via Zoom on Friday, September 9 and Saturday, September 10. For those who couldn’t attend, we have the recording available here.
The Symposium is hosted by the UMass Chan Medical School
in collaboration with Massachusetts General Hospital and the
Deater Foundation, Inc.
The meeting will be held on Zoom. Please see the link below:
HSAN1 Symposium Zoom Link for both days
There is time planned at the end of the meeting to answer questions
of general interest from those attending.
Hereditary Sensory and Autonomic Neuropathy Type 1 (HSAN1) is a rare autosomal dominantly inherited neuropathy, clinically characterized initially by a loss of distal peripheral sensory and motoneuronal function. Mutations in subunits of serine palmitoyltransferase (SPT) have been linked to the majority of HSAN1 cases.
Since 1990 the Deater Foundation has been dedicated to funding HSAN1 research to find a treatment and a cure for the genetic neuromuscular disease Hereditary Sensory and Autonomic Neuropathy Type 1 (HSAN1).
The Deater Family has been involved in research on this disease since 1938. For us, this is personal. At least 6 generations of our family have been diagnosed with HSAN1.
To continue reading this, and much more of our information on HSAN1, Please explore our site’s ‘About‘ & ‘Posts‘ pages. Also, You can join our Facebook group for the Deater Foundation by clicking here.